PO-1015: SBRT after CT-RT for stage III unresectable NSCLC with peripheral primary tumor (GFPC 01-14 study). (November 2020) - Martel-Lafay, I.; Danhier, S.; Blanc, E.; Monnet, I.; Gallocher, O.; Salem, N.; Berard, H.; Bykicki, O.